Oxford Nanopore Technologies plc
General ticker "ONTTF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.7B (TTM average)
Oxford Nanopore Technologies plc follows the US Stock Market performance with the rate: 36.4%.
Estimated limits based on current volatility of 4.2%: low 1.71$, high 1.86$
Short-term ONTTF quotes
Long-term ONTTF plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | £198.60MM | £169.67MM | £183.19MM |
| Operating Expenses | £297.08MM | £338.28MM | £335.52MM |
| Operating Income | £-98.48MM | £-168.61MM | £-152.33MM |
| Non-Operating Income | £15.07MM | £18.84MM | £12.37MM |
| Interest Expense | £1.63MM | £2.21MM | £3.56MM |
| R&D Expense | £64.84MM | £103.84MM | £98.92MM |
| Income(Loss) | £-83.41MM | £-149.77MM | £-139.96MM |
| Profit(Loss)* | £-91.03MM | £-154.51MM | £-146.19MM |
| Stockholders Equity | £693.56MM | £643.85MM | £586.34MM |
| Inventory | £87.70MM | £101.55MM | £99.45MM |
| Assets | £823.89MM | £777.06MM | £742.05MM |
| Operating Cash Flow | £-49.39MM | £-137.30MM | £-109.89MM |
| Capital expenditure | £42.23MM | £27.29MM | £48.64MM |
| Investing Cash Flow | £-65.79MM | £-61.79MM | £15.03MM |
| Financing Cash Flow | £-13.71MM | £64.73MM | £73.58MM |
| Earnings Per Share** | £-0.11 | £-0.19 | £-0.16 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.